Screening tools for hereditary hemolytic anemia: new concepts and strategies

References

• Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112(10):3939–3948.
   PubMed Web of Science ®Google Scholar
• Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372(9647):1411–1426.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Andolfo I, Russo R. Advances in understanding the pathogenesis of red cell membrane disorders. Br J Haematol. 2019;187(1):13–24.
   PubMed Web of Science ®Google Scholar
• Caulier A, Rapetti-Mauss R, Guizouarn H, et al. Primary red cell hydration disorders: pathogenesis and diagnosis. Int J Lab Hematol. 2018;40(Suppl 1):68–73.
   PubMedGoogle Scholar
• van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood. 2005;106(13):4034–4042.
   PubMed Web of Science ®Google Scholar
• Koralkova P, van Solinge WW, van Wijk R. Rare hereditary red blood cell enzymopathies associated with hemolytic anemia - pathophysiology, clinical aspects, and laboratory diagnosis. Int J Lab Hematol. 2014;36(3):388–397.
   PubMed Web of Science ®Google Scholar
• Grace RF, Glader B. Red blood cell enzyme disorders. Pediatr Clin North Am. 2018;65(3):579–595.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Andolfo I, Russo R. Congenital dyserythropoietic anemias. Blood. 2020;136(11):1274–1283.
   PubMed Web of Science ®Google Scholar
• Renella R, Wood WG. The congenital dyserythropoietic anemias. Hematol Oncol Clin North Am. 2009;23(2):283–306.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Andolfo I, Barcellini W, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica. 2017;102 (8):1304–1313.
   Web of Science ®Google Scholar
• Bianchi P, Fermo E. Molecular heterogeneity of pyruvate kinase deficiency. Haematologica. 2020;105(9):2218–2228. .
   PubMed Web of Science ®Google Scholar
• Vercellati C, Bianchi P, Marcello AP, et al. Inherited hemolytic anemias. Haematologica. 2020;1:204–217.
   Google Scholar
• Constantino BT. Reporting and grading of abnormal red blood cell morphology. Int J Lab Hematol. 2015;37(1):1–7.
   PubMed Web of Science ®Google Scholar
• Bain BJ. Diagnosis from the Blood Smear. N Engl J Med. 2005;353(5):498–507.
   PubMed Web of Science ®Google Scholar
• Egelé A, Stouten K, van der Heul-nieuwenhuijsen L, et al. Classification of several morphological red blood cell abnormalities by DM96 digital imaging. Int J Lab Hematol. 2016;38(5):e98–e101.
   PubMed Web of Science ®Google Scholar
• Huisjes R, van Solinge WW, Levin MD, et al. Digital microscopy as a screening tool for the diagnosis of hereditary hemolytic anemia. Int J Lab Hematol. 2018;40(2):159–168.
   PubMed Web of Science ®Google Scholar
• Abay A, Simionato G, Chachanidze R, et al. Glutaraldehyde - A Subtle Tool in the Investigation of Healthy and Pathologic Red Blood Cells. Front Physiol. 2019;10:514.
   PubMed Web of Science ®Google Scholar
• King MJ, Garçon L, Hoyer JD, et al., ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 37(3): 304–325. 2015.
   PubMed Web of Science ®Google Scholar
• Ciepiela O. Old and new insights into the diagnosis of hereditary spherocytosis. Ann Transl Med. 2018;6(17):339.
   PubMed Web of Science ®Google Scholar
• Mariani M, Barcellini W, Vercellati C, et al. Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect. Haematologica. 2008;93(9):1310–1317.
   PubMed Web of Science ®Google Scholar
• Saada V, Cynober T, Brossard Y, et al. Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatric Hematol Oncol. 2006;23(5):387–397.
   PubMed Web of Science ®Google Scholar
• Steward SC, Chauvenet AR, O’Suoji C. Hereditary spherocytosis: consequences of delayed diagnosis. SAGE Open Med. 2014;2:2050312114547093.
   Google Scholar
• Mullier F, Lainey E, Fenneteau O, et al., Additional erythrocytic and reticulocytic parameters helpful for diagnosis of hereditary spherocytosis: results of a multicentre study. Ann Hematol. 90(7): 759–768. 2011.
   PubMed Web of Science ®Google Scholar
• Broséus J, Visomblain B, Guy J, et al. Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis. Int J Lab Hematol. 2010;32(5):519–523.
   PubMed Web of Science ®Google Scholar
• Lazarova E, Pradier O, Cotton F, et al. Automated reticulocyte parameters for hereditary spherocytosis screening. Ann Hematol. 2014;93(11):1809–1818.
   PubMed Web of Science ®Google Scholar
• Farias MG, Freitas PA. Percentage of hyperdense cells: automated parameter to hereditary spherocytosis screening. Clin Biochem. 2015;48(18):1341–1343.
   PubMed Web of Science ®Google Scholar
• Farias MG. Advances in laboratory diagnosis of hereditary spherocytosis. Clin Chem Lab Med. 2017;55(7):944–948.
   PubMed Web of Science ®Google Scholar
• Rooney S, Hoffmann JJ, Cormack OM, et al. Screening and confirmation of hereditary spherocytosis in children using a CELL-DYN Sapphire haematology analyser. Int J Lab Hematol. 2015;37:98–104.
   PubMed Web of Science ®Google Scholar
• Persijn L, Bonroy C, Mondelaers V, et al. Screening for hereditary spherocytosis in routine practice: evaluation of a diagnostic algorithm with focus on non-splenectomised patients. Ann Hematol. 2012;91(2):301–302.
   PubMed Web of Science ®Google Scholar
• Nivaggioni V, Bouriche L, Coito S, et al. Use of Sysmex XN-10 red blood cell parameters for screening of hereditary red blood cell diseases and iron deficiency anaemia. Int J Lab Hematol. 2020;42(6):697–704.
   PubMed Web of Science ®Google Scholar
• Danise P, Amendola G, Nobili B, et al. Flow-cytometric analysis of erythrocytes and reticulocytes in congenital dyserythropoietic anaemia type II (CDA II): value in differential diagnosis with hereditary spherocytosis. Clin Lab Haematol. 2001;23(1):7–13. .
   PubMedGoogle Scholar
• Bobée V, Daliphard S, Schrapp A, et al. Screening of hereditary spherocytosis and pyruvate kinase deficiency by automated blood count using erythrocytic and reticulocytic parameters. Int J Lab Hematol. 2018;40(6):697–703.
   PubMed Web of Science ®Google Scholar
• Arora RD, Dass J, Maydeo S, et al. Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis. Hematology. 2018;23(7):413–416.
   PubMed Web of Science ®Google Scholar
• Chiron M, Cynober T, Mielot F, et al. The GEN.S: a fortuitous finding of a routine screening test for hereditary spherocytosis. Hematol Cell Ther. 1999;41(3):113–116. .
   PubMedGoogle Scholar
• Da Costa L, Mohandas N, Sorette M, et al. Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood. 2001;98(10):2894–2899.
   PubMed Web of Science ®Google Scholar
• Sottiaux JY, Favresse J, Chevalier C, et al. Evaluation of a hereditary spherocytosis screening algorithm by automated blood count using reticulocytes and erythrocytic parameters on the Sysmex XN-series. Int J Lab Hematol. 2020;42(2):e88–e91.
   PubMed Web of Science ®Google Scholar
• King MJ, Behrens J, Rogers C, et al. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol. 2000;111(3):924–933.
   PubMed Web of Science ®Google Scholar
• Bianchi P, Fermo E, Vercellati C, et al., Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica. 97(4): 516–523. 2012.
   PubMed Web of Science ®Google Scholar
• Joshi P, Aggarwal A, Jamwal M, et al. A comparative evaluation of Eosin-5ʹ-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis. Int J Lab Hematol. 2016;38(5):520–526. .
   PubMed Web of Science ®Google Scholar
• Arora RD, Dass J, Maydeo S, et al. Flow cytometric osmotic fragility test and eosin-5ʹ-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis. Int J Lab Hematol. 2018;40(3):335–342.
   PubMed Web of Science ®Google Scholar
• Bolton-Maggs P, Langer JC, Iolascon A, et al. Guidelines for the diagnosis and management of hereditary spherocytosis - 2011 update. Br J Haematol. 2012;156(1):37–49.
   PubMed Web of Science ®Google Scholar
• Suemori SI, Wada H, Nakanishi H, et al. Analysis of hereditary elliptocytosis with decreased binding of eosin-5-maleimide to red blood cells. Biomed Res Int. 2015; . 451861.
   Google Scholar
• Hunt L, Greenwood D, Heimpel H, et al. Toward the harmonization of result presentation for the eosin-5ʹ-maleimide binding test in the diagnosis of hereditary spherocytosis. Cytometry B Clin Cytom. 2015;88:50–57.
   PubMed Web of Science ®Google Scholar
• Mackiewicz G, Bailly F, Favre B, et al. Flow cytometry test for hereditary spherocytosis. Haematologica. 2012;97(12):e47.
   PubMed Web of Science ®Google Scholar
• Mayeur-Rousse C, Gentil M, Botton J, et al. Testing for hereditary spherocytosis: a French experience. Haematologica. 2012;97(12):e48–e49.
   PubMed Web of Science ®Google Scholar
• Zaidi AU, Buck S, Gadgeel M, et al. Clinical diagnosis of red cell membrane disorders: comparison of osmotic gradient ektacytometry and eosin maleimide (EMA) fluorescence test for red cell band 3 (AE1, SLC4A1) content for clinical diagnosis. Front Physiol. 2020;11:636.
   PubMed Web of Science ®Google Scholar
• Falay M, Ulusan GE, Şenes M, et al. Are the reference ranges and cutoff values of eosin-5ʹ-maleimide (ema) binding test for hereditary spherocytosis specific for each age group? Clin Lab. 2018;64(6):1101–1103.
   PubMed Web of Science ®Google Scholar
• Ciepiela O, Adamowicz-Salach A, Bystrzycka W, et al. Mean corpuscular volume of control red blood cells determines the interpretation of eosin-5ʹ-maleimide (EMA) test result in infants aged less than 6 months. Ann Hematol. 2015;94:(8):1277–1283.
   PubMed Web of Science ®Google Scholar
• Ciepiela O, Nowak M, Wrońska M, et al. Eosin-5ʹ-maleimide binding test-Do we use appropriate reference values to detect hereditary spherocytosis in neonates? Int J Lab Hematol. 2019;41(3):e57–e60.
   PubMed Web of Science ®Google Scholar
• Glenthøj A, Sharfo A, Brieghel C, et al. Improving the EMA binding test by using commercially available fluorescent beads. Front. Physiol. 2020;11:569289.
   Web of Science ®Google Scholar
• Warang P, Gupta M, Kedar P, et al. Flow cytometric osmotic fragility–an effective screening approach for red cell membranopathies. Cytometry B Clin Cytom. 2011;80(3):186–190.
   PubMedGoogle Scholar
• Ciepiela O, Adamowicz-Salach A, Zgodzińska A, et al. Flow cytometric osmotic fragility test: increased assay sensitivity for clinical application in pediatric hematology. Cytometry B Clin Cytom. 2018;94(1):189–195.
   PubMed Web of Science ®Google Scholar
• Cheli E, Roze J, Daouairi N, et al. Value of combined spherocytose osmotic and EMA tests in the diagnosis of hereditary spherocytosis. Int J Lab Hematol. 2019;41(4):e84–e85.
   PubMed Web of Science ®Google Scholar
• More TA, Dalal B, Devendra R, et al. Applications of imaging flow cytometry in the diagnostic assessment of red cell membrane disorders. Cytometry B Clin Cytom. 2020;98(3):238–249.
   PubMed Web of Science ®Google Scholar
• Da Costa L, Suner L, Galimand J, et al. Society of hematology and pediatric immunology (SHIP) group; french society of hematology (SFH). Diagnostic tool for red blood cell membrane disorders: assessment of a new generation ektacytometer. Blood Cells Mol Dis. 2016;56(1):9–22.
   PubMedGoogle Scholar
• Lazarova E, Gulbis B, Oirschot BV, et al. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience. Clin Chem Lab Med. 2017;55(3):394–402.
   PubMed Web of Science ®Google Scholar
• Llaudet-Planas E, Vives-Corrons JL, Rizzuto V, et al. Osmotic gradient ektacytometry: a valuable screening test for hereditary spherocytosis and other red blood cell membrane disorders. Int J Lab Hematol. 2018;40(1):94–102.
   PubMed Web of Science ®Google Scholar
• van Vuren A, van der Zwaag B, Huisjes R, et al. The complexity of genotype-phenotype correlations in hereditary spherocytosis: a cohort of 95 patients: genotype-phenotype correlation in hereditary spherocytosis. Hemasphere. 2019;3(4):e276.
   PubMed Web of Science ®Google Scholar
• Zaninoni A, Fermo E, Vercellati C, et al. Use of laser assisted optical rotational cell analyzer (LoRRca MaxSis) in the diagnosis of RBC membrane disorders, enzyme defects, and congenital dyserythropoietic anemias: a monocentric study on 202 patients. Front Physiol. 2018;9:451.
   PubMed Web of Science ®Google Scholar
• Fermo E, Bogdanova A, Petkova-Kirova P, et al. ‘Gardos channelopathy’: a variant of hereditary Stomatocytosis with complex molecular regulation. Sci Rep. 2017;7(1):1744.
   PubMedGoogle Scholar
• Dobbe JGG, Streekstra GJ, Hardeman MR. Measurement of the distribution of red blood cell deformability using an automated rheoscope.. Cytometry. 2002;50(313–25):313–325.
   PubMedGoogle Scholar
• Moura PL, Dobbe JGG, Streekstra GJ, et al. Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning. Br J Haematol. 2020;190(4):e250–e255.
   PubMed Web of Science ®Google Scholar
• Risoluti R, Caprari P, Gullifa G, et al. Differential diagnosis of hereditary hemolytic anemias in a single multiscreening test by TGA/chemometrics. Chem Commun. 2020;56(55):7557–7560.
   PubMed Web of Science ®Google Scholar
• Agarwal AM, Nussenzveig RH, Reading NS, et al. Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. Br J Haematol. 2016;174(5):806–814.
   PubMed Web of Science ®Google Scholar
• Del Orbe Barreto R, Arrizabalaga B, De la Hoz AB, et al. Detection of new pathogenic mutations in patients with congenital haemolytic anaemia using next-generation sequencing. Int J Lab Hematol. 2016;38(6):629–638.
   PubMed Web of Science ®Google Scholar
• Roy NBA, Wilson EA, Henderson S, et al. A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias. Br J Haematol. 2016;175(2):318–330.
   PubMed Web of Science ®Google Scholar
• He Y, Jia S, Dewan RK, et al. Novel mutations in patients with hereditary red blood cell membrane disorders using next-generation sequencing. Gene. 2017;627:556–562.
   PubMed Web of Science ®Google Scholar
• Li Y, Peng GX, Gao QY, et al. Using target next-generation sequencing assay in diagnosing of 46 patients with suspected congenital anemias. Zhonghua Xue Ye Xue Za Zhi. 2018;39(5):414–419.
   PubMedGoogle Scholar
• Shefer-Averbuch N, Steinberg-Shemer O, Dgany O, et al. Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias. Eur J Haematol. 2018;101(3):297–304.
   PubMed Web of Science ®Google Scholar
• Russo R, Andolfo I, Manna F, et al. Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias. Am J Hematol. 2018;93(5):672–682.
   PubMed Web of Science ®Google Scholar
• Kedar PS, Harigae H, Ito E, et al. Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach. Int J Hematol. 2019;110(5):618–626.
   PubMed Web of Science ®Google Scholar
• Kedar PS, Gupta V, Dongerdiye R, et al. Molecular diagnosis of unexplained haemolytic anaemia using targeted next-generation sequencing panel revealed (p.Ala337Thr) novel mutation in GPI gene in two Indian patients. J Clin Pathol. 2019;72(1):81–85.
   PubMed Web of Science ®Google Scholar
• Rets A, Clayton AL, Christensen RD, et al. Molecular diagnostic update in hereditary hemolytic anemia and neonatal hyperbilirubinemia. Int J Lab Hematol. 2019;41(Suppl 1):95–101.
   PubMedGoogle Scholar
• Risinger M, Emberesh M, Kalfa TA. Rare hereditary hemolytic anemias: diagnostic approach and considerations in management. Hematol Oncol Clin North Am. 2019;33(3):373–392.
   PubMed Web of Science ®Google Scholar
• Steinberg-Shemer O, Tamary H. Impact of next-generation sequencing on the diagnosis and treatment of congenital anemias. Mol Diagn Ther. 2020;24(4):397–407.
   PubMed Web of Science ®Google Scholar
• Bianchi P, Vercellati C, Fermo E. How will next generation sequencing (NGS) improve the diagnosis of congenital hemolytic anemia? Ann Transl Med. 2020;8(268):268.
   PubMedGoogle Scholar
• Engert A, Balduini C, Brand A, et al. The european hematology association roadmap for european hematology research: a consensus document. EHA roadmap for European Hematology research. Haematologica. 2016;101(2):115–208.
   PubMed Web of Science ®Google Scholar
• Grace RF, Rose C, Layton DM, et al. Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency. N Engl J Med. 2019;381(10):933–944.
   PubMed Web of Science ®Google Scholar
• Quintana-Bustamante O, Fañanas-Baquero S, Orman I, et al. Gene editing of PKLR gene in human hematopoietic progenitors through 5’ and 3’ UTR modified TALEN mRNA. PLoS One. 2019;14(10):e0223775.
   PubMed Web of Science ®Google Scholar
• Picard V, Guitton C, Thuret I, et al., Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos channelopathy: a retrospective series of 126 patients. Haematologica. 104(8): 1554–1564. 2019. .
   PubMed Web of Science ®Google Scholar
• Pellegrin S, Haydn-Smith KL, Hampton-O’Neil LA, et al. Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII. Br J Haematol. 2019;184(5):876–881.
   PubMed Web of Science ®Google Scholar
• Kaestner L, Bianchi P. Trends in the development of diagnostic tools for red blood cell-related diseases and anemias. Front Physiol. 2020;11:387.
   PubMed Web of Science ®Google Scholar
• Rab MAE, Kanne CK, Bos J, et al. Methodological aspects of the oxygenscan in sickle cell disease: a need for standardization. Am J Hematol. 2020;95(1):E5–E8.
   PubMed Web of Science ®Google Scholar
• Rotordam MG, Fermo E, Becker N, et al. A novel gain-of-function mutation of Piezo1 is functionally affirmed in red blood cells by high-throughput patch clamp. Haematologica. 2019;104(5):e179–e183.
   PubMed Web of Science ®Google Scholar